Chronic Myeloid Leukemia‎

Some Discrepancies Seen Between Real-Life and Guideline-Recommended Care of Chronic Myeloid Leukemia

By

Megan Garlapow, PhD

Publish Date August 20, 2019

An assessment of a population of patients with CML revealed that some are not receiving guideline-based treatment, including TKIs.

10-Year OS After Bone Marrow Transplantation for CML Similar With/Without Prior TKI Therapy

By

Susan Moench, PhD, PA-C

Publish Date August 16, 2019

Researchers sought to determine whether late mortality rates are affected by exposure to a BCR-ABL TKI prior to BMT in patients with CML who survive at least 2 years posttransplantation.

How to Select the Optimal BCR-ABL TKI Therapy for Treatment of Chronic-Phase CML

By

Susan Moench, PhD, PA-C

Publish Date August 7, 2019

Key factors that influence choice of TKI for frontline treatment of chronic-phase CML are reviewed, as well as the role for pharmacists in the multidisciplinary oncology care team.

TKI Dose Reduction Improves Treatment-Free Remission Protocols for Chronic Myeloid Leukemia

By

Susan Moench, PhD, PA-C

Publish Date July 17, 2019

Study sought to determine the effects of dose reductions in TKI therapy prior to complete cessation improves treatment-free remission in patients with CML.

Increased Incidence of Second Malignancies in Patients With Chronic Myeloid Leukemia

By

Sonali Gattani

Publish Date May 21, 2019

Researchers assessed 13,276 patients with chronic myeloid leukemia to characterize the incidence and types of second malignancies in this patient population.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .